TrialBritish journal of cancer1999

Phase II study of RC-160 (vapreotide), an octapeptide analogue of somatostatin, in the treatment of metastatic breast cancer.

K J O'Byrne et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.